35
Participants
Start Date
April 10, 2018
Primary Completion Date
October 12, 2021
Study Completion Date
October 12, 2021
Efavaleukin Alfa
Efavaleukin Alfa will be administered by subcutaneous (SC) injection in the abdomen, thigh or upper arm.
Placebo
The placebo will be administered by subcutaneous (SC) injection in the abdomen, thigh or upper arm.
Charite Universitätsmedizin Berlin, Berlin
Northwell Health, Great Neck
Hopital Europeen Marseille, Marseille
Altoona Center for Clinical Research, Duncansville
Translational Clinical Research LLC, Aventura
Pinnacle Research Group LLC, Anniston
Centre Hospitalier Régional Universitaire de Lille - Hôpital Claude Huriez, Lille
Centre Hospitalier Universitaire de Strasbourg - Nouvel hopital civil, Strasbourg
Hopital Pitie-Salpetriere, Paris
Metroplex Clinical Research Center, Dallas
Wallace Rheumatic Studies Center LLC, Beverly Hills
Clinical Research Center Spzoo Medic-R Spolka Komandytowa, Poznan
Tomasz Blicharski Lubelskie Centrum Diagnostyczne, Świdnik
Medycyna Kliniczna Marzena Waszczak - Jeka, Warsaw
Wojewodzki Szpital Specjalistyczny we Wroclawiu, Wroclaw
Lead Sponsor
Amgen
INDUSTRY